Polomar Health Services, Inc.
For the period ended Dec 31, 2024. Filed May 22, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 22, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
The Company has elected not to provide summary information.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Polomar Health Services, Inc.
/s/ Terrence M. Tierney
Terrence M. Tierney
President and Chief Executive Officer
Dated: May 22, 2025
/s/ Charlie Lin
Charlie Lin Treasurer and Chief Financial Officer
Dated: May 22, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Terrence M. Tierney | President, Chief Executive Officer and Director | May 22, 2025 |
| Terrence M. Tierney | (Principal Executive, Financial and Accounting Officer) | |
| /s/ Gabriel Del Virginia | Director | May 22, 2025 |
| Gabriel Del Virginia | ||
| /s/ David Spiegel | Director | May 22, 2025 |
| David Spiegel | ||
INDEX TO FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 6580) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Comprehensive Loss for the years ended December 31, 2024 and 2023 | F-5 |
| Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2024 and 2023 | F-6 |
| Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023 | F-7 |
| Notes to the Consolidated Financial Statements | F-8 - F-16 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.